Identification and Validation of Immune-Related Genes Diagnostic for Progression of Atherosclerosis and Diabetes

References

• Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8:e721–e729. doi:10.1016/S2214-109X(20)30117-0
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Cao Y, et al. Targeting the microenvironment of vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis. Adv Mater. 2022;34:e2110660. doi:10.1002/adma.202110660
   Google Scholar
• Kovanen PT. Mast cells as potential accelerators of human atherosclerosis-from early to late lesions. Int J Mol Sci. 2019;20:4479. doi:10.3390/ijms20184479
   PubMed Web of Science ®Google Scholar
• Tomaniak M, Katagiri Y, Modolo R, et al. Vulnerable plaques and patients: state-of-The-art. Eur Heart J. 2020;41:2997–3004. doi:10.1093/eurheartj/ehaa227
   PubMed Web of Science ®Google Scholar
• Ferket BS, Hunink MGM, Masharani U, et al. Lifetime cardiovascular disease risk by coronary artery calcium score in individuals with and without diabetes: an analysis from the multi-ethnic study of atherosclerosis. Diabetes Care. 2022;45:975–982. doi:10.2337/dc21-1607
   Google Scholar
• Yahagi K, Kolodgie FD, Lutter C, et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2017;37:191–204. doi:10.1161/ATVBAHA.116.306256
   PubMed Web of Science ®Google Scholar
• Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular disease in diabetes, beyond glucose. Cell Metab. 2021;33:1519–1545. doi:10.1016/j.cmet.2021.07.001
   Web of Science ®Google Scholar
• Li Q, Fu J, Xia Y, et al. Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes. Nat Commun. 2019;10:4427. doi:10.1038/s41467-019-12368-2
   Web of Science ®Google Scholar
• Rask-Madsen C, Li Q, Freund B, et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 2010;11:379–389. doi:10.1016/j.cmet.2010.03.013
   PubMed Web of Science ®Google Scholar
• Mendiola AS, Ryu JK, Bardehle S, et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020;21:513–524. doi:10.1038/s41590-020-0654-0
   PubMed Web of Science ®Google Scholar
• Chen P, Chen Y, Wu W, Chen L, Yang X, Zhang S. Identification and validation of four hub genes involved in the plaque deterioration of atherosclerosis. Aging. 2019;11:6469–6489. doi:10.18632/aging.102200
   PubMedGoogle Scholar
• Zhong M, Wu Y, Ou W, Huang L, Yang L. Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study. Biosci Rep. 2019;39. doi:10.1042/BSR20182172
   Google Scholar
• Ding L, Fan L, Xu X, Fu J, Xue Y. Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis. Mol Med Rep. 2019;20:2597–2608. doi:10.3892/mmr.2019.10522
   Google Scholar
• Jiao M, Li J, Zhang Q, et al. Identification of four potential biomarkers associated with coronary artery disease in non-diabetic patients by gene co-expression network analysis. Front Genet. 2020;11:542. doi:10.3389/fgene.2020.00542
   Google Scholar
• Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264. doi:10.1093/biostatistics/4.2.249
   PubMed Web of Science ®Google Scholar
• Reimers M, Carey VJ. Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol. 2006;411:119–134.
   PubMed Web of Science ®Google Scholar
• Vella D, Marini S, Vitali F, Di Silvestre D, Mauri G, Bellazzi R. MTGO: PPI network analysis via topological and functional module identification. Sci Rep. 2018;8:5499. doi:10.1038/s41598-018-23672-0
   Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Li L, Lei Q, Zhang S, Kong L, Qin B. Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis. Oncol Rep. 2017;38:2607–2618. doi:10.3892/or.2017.5946
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Subramanian A, Narayan R, Corsello SM, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437–1452 e17. doi:10.1016/j.cell.2017.10.049
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Cannon CP, Pratley R, Dagogo-Jack S, et al.; V.C. Investigators. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med. 2020;383:1425–1435. doi:10.1056/NEJMoa2004967
   PubMed Web of Science ®Google Scholar
• Nissen SE, Nicholls SJ, Wolski K, et al.; P. Investigators. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA. 2008;299:1561–1573. doi:10.1001/jama.299.13.1561
   PubMed Web of Science ®Google Scholar
• Ogasawara D, Shite J, Shinke T, et al. Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus. Circ J. 2009;73:343–351. doi:10.1253/circj.CJ-08-0699
   Google Scholar
• Vaccaro O, Masulli M, Nicolucci A, et al. Thiazolidinediones or sulfonylureas cardiovascular accidents intervention trial study, and S. Italian diabetes, effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. Lancet Diabetes Endocrinol. 2017;5:887–897. doi:10.1016/S2213-8587(17)30317-0
   PubMed Web of Science ®Google Scholar
• Cochain C, Zernecke A. Protective and pathogenic roles of CD8(+) T cells in atherosclerosis. Basic Res Cardiol. 2016;111:71. doi:10.1007/s00395-016-0589-7
   PubMed Web of Science ®Google Scholar
• Shin JJ, Lee EK, Park TJ, Kim W. Damage-associated molecular patterns and their pathological relevance in diabetes mellitus. Ageing Res Rev. 2015;24:66–76.
   Google Scholar
• Reddy SS, Agarwal H, Jaiswal A, Jagavelu K, Dikshit M, Barthwal MK. Macrophage p47(phox) regulates pressure overload-induced left ventricular remodeling by modulating IL-4/STAT6/PPARgamma signaling. Free Radic Biol Med. 2021;168:168–179.
   Google Scholar
• Vinu EA, MartInez-Hervas S, Herrero-Cervera A, et al. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus. Transl Res. 2019;203:31–48.
   Google Scholar
• Shi J, Lu P, Shen W, et al. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer. Cancer Lett. 2019;453:158–169.
   Google Scholar
• Flynn MC, Kraakman MJ, Tikellis C, et al. Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis. Circ Res. 2020;127:877–892.
   Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41:D991–5.
   PubMed Web of Science ®Google Scholar
• Engelen SE, Robinson AJB, Zurke YX, Monaco C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol. 2022;2022:1.
   Google Scholar
• Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36–46.
   PubMed Web of Science ®Google Scholar
• Prattichizzo F, De Nigris V, Spiga R, et al. Inflammageing and metaflammation: the yin and yang of type 2 diabetes. Ageing Res Rev. 2018;41:1–17.
   PubMed Web of Science ®Google Scholar
• Ying W, Fu W, Lee YS, Olefsky JM. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol. 2020;16:81–90.
   PubMed Web of Science ®Google Scholar
• Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56:2356–2370.
   PubMed Web of Science ®Google Scholar
• Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. 2020;17:387–401.
   PubMed Web of Science ®Google Scholar
• Han M, Ma K, Wang X, et al. Immunological characteristics in type 2 diabetes mellitus among COVID-19 patients. Front Endocrinol. 2021;12:596518.
   Google Scholar
• Cifuentes-Mendiola SE, Solis-Suarez DL, Martinez-Davalos A, Godinez-Victoria M, Garcia-Hernandez AL. CD4(+) T-cell activation of bone marrow causes bone fragility and insulin resistance in type 2 diabetes. Bone. 2022;155:116292.
   Web of Science ®Google Scholar
• Ratter-Rieck JM, Maalmi H, Trenkamp S, et al.; German Diabetes Study, and G.D.S. Group. Leukocyte counts and T-cell frequencies differ between novel subgroups of diabetes and are associated with metabolic parameters and biomarkers of inflammation. Diabetes. 2021;70:2652–2662.
   Web of Science ®Google Scholar
• Gailani D, Fisher TC, Mills DC, Macfarlane DE. P47 phosphoprotein of blood platelets (pleckstrin) is a major target for phorbol ester-induced protein phosphorylation in intact platelets, granulocytes, lymphocytes, monocytes and cultured leukaemic cells: absence of P47 in non-haematopoietic cells. Br J Haematol. 1990;74:192–202.
   PubMed Web of Science ®Google Scholar
• Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol. 2007;179:647–654.
   Google Scholar
• Lundmark A, Davanian H, Bage T, et al. Transcriptome analysis reveals mucin 4 to be highly associated with periodontitis and identifies pleckstrin as a link to systemic diseases. Sci Rep. 2015;5:18475.
   PubMed Web of Science ®Google Scholar